» Articles » PMID: 12420367

Diabetes, the Brain, and Behavior: is There a Biological Mechanism Underlying the Association Between Diabetes and Depression?

Overview
Date 2002 Nov 8
PMID 12420367
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In summary, our review of the literature suggests that diabetes, especially type 1 diabetes, may place patients at risk for a depressive disorder through a biological mechanism linking the metabolic changes of diabetes to changes in brain structure and function. Further studies are warranted examining these relationships in order to better understand the impact of diabetes on brain functioning and structure as well as one potential manifestation of such changes--affective disorder. Moreover, such studies could play a useful role in better understanding mechanisms that commonly underlie the development of depression in individuals without diabetes but with other medical problems or conditions.

Citing Articles

The combined association of adherence to recommended physical activity and glycemic control with depression: an exploratory study with mediation and moderation models.

Zou Y, Meng F, Yan X BMC Public Health. 2023; 23(1):2146.

PMID: 37919713 PMC: 10623723. DOI: 10.1186/s12889-023-17063-y.


Potential therapeutic effect of NK1R antagonist in diabetic non-healing wound and depression.

Li M, Ma H, Zhang S, Peng Y, Ding L, Zhang Y Front Endocrinol (Lausanne). 2023; 13:1077514.

PMID: 36686487 PMC: 9845920. DOI: 10.3389/fendo.2022.1077514.


Diabetic Encephalopathy in a Preclinical Experimental Model of Type 1 Diabetes Mellitus: Observations in Adult Female Rat.

Falvo E, Giatti S, Diviccaro S, Cioffi L, Herian M, Brivio P Int J Mol Sci. 2023; 24(2).

PMID: 36674713 PMC: 9860834. DOI: 10.3390/ijms24021196.


Prevalence of Depression among Patients with Type 2 Diabetes Mellitus and its associated Clinical Factors.

Victoria G, Dampil A J ASEAN Fed Endocr Soc. 2021; 34(2):197-203.

PMID: 33442156 PMC: 7784119. DOI: 10.15605/jafes.034.02.11.


The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus.

Pittala S, Levy I, De S, Pandey S, Melnikov N, Hyman T Cells. 2020; 9(2).

PMID: 32093016 PMC: 7072803. DOI: 10.3390/cells9020481.